Education:


Columbia University - Business School NY/USA

Master of Business Administration (Hons.)


Zurich School of Management

Degree in Business Administration and Economics (Betriebsökonom KSZ)


KV Business School

Federal degree in Banking

(Eidgenössisch diplomierter Bankfachmann)


KV Business School

Trade school degree in commerce

(Lehre kaufmännischer Angestellter)



My international experience for you.

 

Iris Maria Welten is Chair, Vice-Chair and Board member and member of advisory boards of several companies as well as co-founder of the consulting firm for Board of Directors Welten & Welten AG. Further, she teaches at the University of Applied Sciences Bern and Basel, Corporate Governance and Public Management. Her profound experience includes international capital markets, leadership of 8 country representatives, broad industry experience (6 industries) and the management of 9 units. In addition, she is well connected economically as well as politically (communal, state and federal level). She worked in Munich, Miami, Hong Kong and New York for large stock exchange listed companies in leading Group Corporate functions as well as CEO.

My international experience for you.


Harry Welten has more than a decade of Board of Directors experience in listed and privately held biotech companies as Chairman, Vice-Chairman and member of the Board of Directors. Further, he has extensive hands-on experience as Audit Commitee Chair as well as Chair of the Nomination and Compensation Commitee. He has more than 20 years of comprehensive U.S. and European executive management experience in Biotech/ Pharma and Banking. Harry is a past Chief Financial Officer of several SIX Swiss Exchange Main Segment listed biotech companies and was a key player in one of the largest biotech IPO’s in Europe as well as in numerous industry shaping deals such as M&A as well as spin-offs. During his tenure as CFO, Harry raised more than CHF 320 mln through Venture Capital rounds/M&A/IPO/capital markets in Europe and the U.S.. In addition, he successfully managed the transition from a private equity financed business into a SIX Swiss Exchange main segment listed company including private and public fund raising. Last but not least he was responsible for Corporate Functions such as Corporate Governance, Risk Management, Corporate Finance, Corporate Communications, IT, Legal, Human Resources, Investor Relations and Strategy.

IRIS'

STORY

HARRY'S

STORY

Current Mandates:


  • Chair Board of Directors & CEO,
    Welten & Welten AG
  • Vice-Chair BoD, Business Angels Aargau
  • BoD (Finance), Alterszentrum Blumenheim
  • Advisory Board, Equity Pitcher
  • Member selection commitee BIC (Busi-
    ness Incubation Centre) CERN Technology
  • Institute member (Responsible
    Leadership), IFAM Research Center
  • Lecturer University of Applied Sciences Bern and Basel

 

Work Experience:

 

BaselArea, CEO

Settlement of companies and provide access to commercial properties, active in eight countries
on behalf of four cantons. Focus on:

strategy - efficiency - key account management.

 

Zur Rose AG, SeniorVP, Head Corporate Services

Responsible for business development, public affairs, corporate communications and certified quality assurance. Focus on:

M&A - strategy - corporate management.

 

Swiss Life AG, SeniorVP, Head Investor Relations

Focus on: corporate governance - shareholder structure & activism - transparency.

 

Clariant Ltd., FirstVP, Head Investor Relations

Focus on: crisis exit strategies -

consensus management - positioning.

 

Deutsche Telekom, Ass. Director, Deputy Head IR

Focus on: US authorities (SEC, NYSE) -

acquisition retail clients - IPO - capital increase.

 

Current Mandates:

 

  • Chairman Board of Directors, Virometrixs
  • Chairman BoD, Juvabis
  • Vice-Chairman of the BoD, Proteomedix
  • Member BoD, Virometix
  • Member BoD, Anokion USA
  • Member HBM Foundation Council



 

 





 

 

 

 

Work Experience:

 

Kuros Biosciences AG, CFO

Listed on the main segment of the SIX Swiss Exchange. Focus on: debt restructuring - equity financing - strategic acquisitions.

 

Nitec Pharma AG, CFO

Merged with Horizon Pharma from the USA, now listed on Nasdaq, USA.

Focus on: M&A negotiation - implementation - execution.

 

Arpida AG (now Evolva Holding AG), CFO

Listed on the main segment of the SIX Swiss Exchange. Focus on: equity financing - IPO - restructuring - reverse merger.

 

UBS AG, Zurich and New York USA, Director

Focus on: client relationships - department integration - loan portfolio repositioning.

Education:


Google Search Inside Yourself Certified Program

Mindful Leadership


University of St. Gallen, Bord of Directors School

Corporate Governance


IMD Lausanne

International Strategy Development


ZFU Zug

Change Management und Leadership


SGO Training AG

“Advanced” Project Management


Train GmbH

Media training and crisis communication


Ludwig-Maximilians-Universität Munich

Master degree in Science of Communication, bachelor in business administration, bachelor in market psychology (summa cum laude)


Welten & Welten AG © Copyright. All Rights Reserved.